11/29/2024Recent Executive Moves

11/28/2024AstraZeneca's Enhertu Secures Reimbursement Listing Despite Ongoing Pr...

11/28/2024BeOne Secures EU Approval for First-Line Checkpoint Blocker

11/28/2024NMPA Solicits Public Comments on the Provisions for the Record Filing ...

11/28/2024NHSA and MOHRSS Announce the 2024 National Drug Reimbursement List

11/28/2024NHSA Issues Guidelines for Managing Pricing Risks of Shortage Drugs

11/27/2024China Introduces New Policy to Strengthen Hierarchical Medical Care an...

11/27/2024NHSA: Policies in Development to Synchronize Medical Insurance Funds a...

11/27/2024Policy Change Set to Advance Cell and Gene Therapy in China

11/27/2024CMS's CMS-D005 Gets Green Light for Its Obesity Drug Trials in China

11/27/2024NMPA Accepts Akeso's sNDA for Penpulimab Plus Anlotinib for Advanced H...

More>>

11/27/2024Asian Market Rattled by Trump Tariffs: Yang Report (LinkedIn)

11/26/2024Rise In Clinical Trial Activity Will Support Hong Kong, China’s Pharm...

11/22/2024Cancer Incidence and Mortality in China, 2022 (JNCC)

11/21/202469 New Drugs Granted Breakthru Therapy Designations in China This Year...

11/20/2024 Promoting Collaboration in Regional Healthcare Systems in Hong Kong, ...

11/20/2024Probe of AstraZeneca Executive in China Raises Questions About Company...

11/19/2024Pharma BoardRoom Interview of Renaud Gabay – Managing Director, RDPAC...

11/19/2024When BeiGene Takes Off 'Bei' and Why NewCo Now: Three Biotech Go Globa...

11/14/2024China on the Move: New Level of Opening up in Health Care Sector (NLR)

11/14/2024Passage to Asia: Early Access for Innovative Therapies (PharmExec)

11/13/2024How China's Anti-Espionage Law Could Impact Pharmaceutical Supply Chai...

More>>